Britt Meelby Jensen
Vermögen: 744 081 $ am 31.05.2026
Vermögen: 744 081 $ am 31.05.2026
Britt Meelby Jensen is currently Chief Executive Officer at Ambu A and Ambu, Inc. since 2019.
Holds director positions at Novo Holdings A (since 2022), Dansk Biotek, BioPorto Diagnostics A (since 2018), Hempel Invest A, Hempel A, and is a Non-Independent Director at Novo Nordisk A starting 2025.
Also serves as Trustee at Hempel Fonden.
Formerly Chief Executive Officer at Atos Medical AB from 2019 to 2022, President & Chief Executive Officer at Zealand Pharma A from 2015 to 2019, Chief Executive Officer at Dako ApS from 2013 to 2014.
Held director roles at Bioporto A and Orana A, and was Vice President & General Manager at Dako Denmark ApS.
Education includes graduate studies at Copenhagen Business School, undergraduate studies at the University of Aarhus, and an MBA from Solvay Business School of Economics & Management.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AMBU A/S CLASS B 0,03 % | 30.09.2025 | 70.702 ( 0,03 % ) | 744 081 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AMBU A/S | Vorstandsvorsitzender | 20.05.2022 |
| NOVO NORDISK A/S | Direktor/Vorstandsmitglied | 14.11.2025 |
Dansk Biotek
Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Operates as an industry association for biotech companies with promoting the biotechnological research | Direktor/Vorstandsmitglied | - |
Ambu, Inc.
Ambu, Inc. Medical DistributorsDistribution Services Wholesales physicians and surgeons equipment | Vorstandsvorsitzender | - |
Hempel A/S
Hempel A/S Industrial SpecialtiesProcess Industries Develops and manufactures coating solutions for protective, decorative, marine, container, industrial & yacht segments | Direktor/Vorstandsmitglied | - |
Novo Holdings A/S (Denmark)
Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Direktor/Vorstandsmitglied | 28.03.2022 |
Hempel Invest A/S
Hempel Invest A/S Financial ConglomeratesFinance Functions as an investment holding company | Direktor/Vorstandsmitglied | - |
Hempel Fonden
Hempel Fonden Miscellaneous Commercial ServicesCommercial Services Provides and maintains a solid economic base for the company | Direktor/Vorstandsmitglied | - |
Bioporto Diagnostics A/S
Bioporto Diagnostics A/S BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Direktor/Vorstandsmitglied | 13.04.2018 |
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 18 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Novo Holdings A/S (Denmark)
Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Finance |
Ambu A/S
Ambu A/S Medical SpecialtiesHealth Technology Manufactures and markets diagnostic and life supporting devices for hospitals | Health Technology |
Bioporto A/S
Bioporto A/S Medical SpecialtiesHealth Technology Develops and markets human and animal neutrophil gelatinase-associated lipocalin antibodies kits | Health Technology |
Atos Medical AB
Atos Medical AB Medical SpecialtiesHealth Technology Develops and manufactures laryngectomy devices | Health Technology |
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Designs and manufactures cancer diagnostic systems | Health Technology |
Copenhagen Business School
Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Aarhus
University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zealand Pharma A/S
Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Hempel A/S
Hempel A/S Industrial SpecialtiesProcess Industries Develops and manufactures coating solutions for protective, decorative, marine, container, industrial & yacht segments | Process Industries |
Dako ApS
Dako ApS Electronic Equipment/InstrumentsElectronic Technology Designs and manufactures cancer diagnostic systems | Electronic Technology |
Dansk Biotek
Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Operates as an industry association for biotech companies with promoting the biotechnological research | Commercial Services |
Ambu, Inc.
Ambu, Inc. Medical DistributorsDistribution Services Wholesales physicians and surgeons equipment | Distribution Services |
Hempel Fonden
Hempel Fonden Miscellaneous Commercial ServicesCommercial Services Provides and maintains a solid economic base for the company | Commercial Services |
Orana A/S
Orana A/S Food: Specialty/CandyConsumer Non-Durables Produces and supplies natural extracts and fruit based food products | Consumer Non-Durables |
Bioporto Diagnostics A/S
Bioporto Diagnostics A/S BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Hempel Invest A/S
Hempel Invest A/S Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Solvay Business School of Economics & Management
Solvay Business School of Economics & Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition